Download

Discipline - Clinical chemistry
Alkaline phosphatase (ALP)
Setting:
2. Laboratory
Tiered Testing Service:
District hospital with laboratory Regional or provincial hospital with laboratory
Assay format
Optical methods on semi-automated or automated clinical chemistry analysers
Information History
First added in 2018
Changed in 2020
Purpose type
Aid to diagnosis
Purpose
To aid in the diagnosis of hepatobiliary and bone disorders.
Specimen types
Serum, Plasma
WHO prequalified or recommended products
N/A
GMDN

52928

Total alkaline phosphatase (ALP) IVD, kit, spectrophotometry

A collection of reagents and other associated materials intended to be used for the qualitative and/or quantitative detection of total alkaline phosphatase (ALP) in a clinical specimen, using a spectrophotometry method.

The medical device term(s), code(s) and definition(s) in this section were retrieved from databases external to WHO. As there might be more than one name, definition and “Nomenclature Code” related to the specific medical device, please consult https://gmdnagency.org GMDN ®. © GMDN Agency 2005-2024
EMDN

W01010105

ALKALINE PHOSPHATASE - TOTAL

The code(s) and term(s) in this section were observed and retrieved from public databases and have not been validated by health regulatory authorities. Please consult your regulatory agency and EMDN site: https://webgate.ec.europa.eu/dyna2/emdn
WHO supporting publications
WHO list of priority medical devices for management of cardiovascular diseases and diabetes. (2021). https://iris.who.int/handle/10665/341967
Technical specifications
N/A
Related Medical Devices in MeDevIS
SAGE IVD recommended including this test in the EDL on the basis of the scientific validity of the analyte. It was recognized that the test is a foundational IVD test and is included in clinical guidelines.
N/A
The inclusion of this test was based on WHO guidelines and/or technical documents that include recommendations for the use of this test.
N/A